Digoxin ToxicityEvaluation in Clinical Practice with Pharmacokinetic Correlations

被引：0
作者：
Karine Lecointre
Laurence Pisanté
Francis Fauvelle
Serge Mazouz
机构：
[1] Centre Hospitalier Intercommunal Le Raincy-Montfermeil,Service Pharmacie
[2] Centre Hospitalier Intercommunal Le Raincy-Montfermeil,Service de Cardiologie
来源：
Clinical Drug Investigation | 2001年 / 21卷
关键词：
Root Mean Square Error; Digoxin; Total Clearance; Digoxin Concentration; Serum Digoxin Concentration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 232
页数：7
相关论文
共 50 条
  • [21] Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin
    S. Snel
    J. A. Jansen
    P. C. Pedersen
    J. H. G. Jonkman
    P. N. M. van Heiningen
    European Journal of Clinical Pharmacology, 1998, 54 : 355 - 357
  • [22] Absence of Pharmacokinetic Interaction Between Roflumilast and Digoxin in Healthy Adults
    Eckermann, Gabriel
    Lahu, Gezim
    Nassr, Nassr
    Bethke, Thomas D.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (02) : 251 - 257
  • [23] Population Pharmacokinetic Investigation of Digoxin in Japanese Infants and Young Children
    Yukawa, Miho
    Yukawa, Eiji
    Suematsu, Fumihiro
    Takiguchi, Takako
    Ikeda, Hirohito
    Aki, Hatsumi
    Mimemoto, Masao
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06) : 857 - 863
  • [24] Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin
    Snel, S
    Jansen, JA
    Pedersen, PC
    Jonkman, JHG
    van Heiningen, PNM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) : 355 - 357
  • [25] Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
    Sreeneeranj Kasichayanula
    Ming Chang
    Xiaoni Liu
    Wen-Chyi Shyu
    Steven C. Griffen
    Frank P. LaCreta
    David W. Boulton
    Advances in Therapy, 2012, 29 : 163 - 177
  • [26] Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters
    Emmanuelle Comets
    Céline Verstuyft
    Marc Lavielle
    Patrice Jaillon
    Laurent Becquemont
    France Mentré
    European Journal of Clinical Pharmacology, 2007, 63 : 437 - 449
  • [27] Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers
    Vousden, M
    Allen, A
    Lewis, A
    Ehren, N
    CHEMOTHERAPY, 1999, 45 (06) : 485 - 490
  • [28] Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters
    Comets, Emmanuelle
    Verstuyft, Celine
    Lavielle, Marc
    Jaillon, Patrice
    Becquemont, Laurent
    Mentre, France
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) : 437 - 449
  • [29] Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
    Kasichayanula, Sreeneeranj
    Chang, Ming
    Liu, Xiaoni
    Shyu, Wen-Chyi
    Griffen, Steven C.
    LaCreta, Frank P.
    Boulton, David W.
    ADVANCES IN THERAPY, 2012, 29 (02) : 163 - 177
  • [30] Practical uses of individual pharmacokinetic parameters in drug development and clinical practice: examples and simulations
    T. D. Bjornsson
    European Journal of Drug Metabolism and Pharmacokinetics, 1997, 22 : 1 - 14
12345